Evotec SE (EVO) Other financing activities (2010 - 2026)

Evotec SE (EVO) reported Other financing activities of $115.9 for Q1 2026, down 47.53% on a YoY basis from $220.9 in Q1 2025, and down 47.53% sequentially from $220.9 in Q1 2025.

Evotec SE (EVO) Other financing activities (2010 - 2026) Analysis & Trends

Evotec SE (EVO) has 6 years of Other financing activities data on file, last reported at $115.9 in Q1 2026.

  • For the quarter ending Q1 2026, Other financing activities fell 47.53% year-over-year to $115.9; the trailing twelve-month figure through Mar 2026 stood at $733.32 (up 18.97% YoY), and the FY2009 full-year result was $387796.0, changed N/A from the prior year.
  • Other financing activities slipped to $115.9 in Q1 2026, from $220.9 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $396.52 in Q1 2024 to a low of -$1.01 in Q3 2022.
  • A 4-year average of $223.9 and a median of $220.9 in 2025 frame the typical range for Other financing activities.
  • Across the five-year window, Other financing activities plunged 100.17% in 2022 and plunged 44.29% in 2025, its largest moves.
  • Tracing EVO's Other financing activities over 4 years: stood at -$1.01 in 2022, then soared by 39426.8% to $396.52 in 2024, then sank by 44.29% to $220.9 in 2025, then tumbled by 47.53% to $115.9 in 2026.
  • Business Quant data shows EVO's Other financing activities at $115.9 in Q1 2026, $220.9 in Q1 2025, and $396.52 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Evotec SE 351.60 Mn 351.08 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 115.90
Mar 31, 2026 115.90
Mar 31, 2025 220.90
Mar 31, 2025 220.90
Mar 31, 2024 396.52
Mar 31, 2024 396.52
Sep 30, 2022 -1.01
Sep 30, 2022 -1.01
Mar 31, 2022 387.21
Mar 31, 2022 387.21
Sep 30, 2021 593.18
Sep 30, 2021 593.18
Jun 30, 2021 56.60
Jun 30, 2021 56.60
Mar 31, 2021 779.23
Mar 31, 2021 779.23
Sep 30, 2010 18.08
Sep 30, 2010 18.08
Jun 30, 2010 193.78
Jun 30, 2010 193.78